Unlike older therapies that target one or two receptors, Retatrutide activates three receptors: GLP-1, GIP, and glucagon
If there are possible cancer-related benefits to being on these drugs, she said, that would be welcome news, given existing cancer treatments can have very intolerable side effects for patients
8 , e2300151 (2024)
Similarly, this latter analysis, which covered nearly 2.25 million patients, did not show an excess risk of suicidal ideation and behavior in patients taking GLP-1s
Not all GLP-1s behaved the same: One study of exendin-4 (exenatide) in mice found no drop in birth weight and even showed increased early growth, highlighting how inconsistent animal results can be
Selecting PEA & ALC PEA is a naturally occurring fatty acid and ALC is present in animal products